Hepcinat-LP Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Ledipasvir (90mg) + Sofosbuvir (400mg)
Overview Hepcinat-LP Tablet
Hepcinat-LP tablets contain a dual antiviral formulation, prescribed for managing chronic hepatitis C (HCV). This medication combats the HCV virus to achieve infection resolution. Adhere strictly to the prescribed dosage and regimen. Consumption with or without food is acceptable, but maintain consistent daily timing. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, particularly liver or kidney ailments, to your physician. Alcohol consumption should be minimized or avoided entirely while using this medication. Complete the entire course for optimal therapeutic outcome. Fatigue and cephalalgia are frequently reported side effects; hydration and a nutritious diet can mitigate these. Prior to initiating treatment, inform your doctor about all other medications or supplements you are currently using.
Uses of Hepcinat-LP Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Hepcinat-LP Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hepcinat-LP Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Hepcinat-LP Tablet:
- Tiredness
- Headache
How to use Hepcinat-LP Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hepcinat-LP Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Hepcinat-LP Tablet works:
Ledipasvir and Sofosbuvir, the active components of Hepcinat-LP tablets, act synergistically to reduce the hepatitis C viral load. This antiviral combination therapy gradually eliminates the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hepcinat-LP Tablet poses an unknown safety risk. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Hepcinat-LP tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; clinical data from human studies, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Use of Hepcinat-LP tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects from Hepcinat-LP Tablets. Concurrent use of Hepcinat-LP Tablets and other hepatitis C medications can lead to dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
Patients with severe kidney impairment should use Hepcinat-LP tablets cautiously, as dose modification may be necessary. Advice from a physician is recommended due to limited data on Hepcinat-LP use in this population. Dosage changes are not typically advised for individuals with mild to moderate kidney disease.
LiverSAFE IF PRESCRIBED
Hepcinat-LP tablets are considered safe for use by individuals with hepatic impairment. No alteration of the Hepcinat-LP tablet dosage is necessary.
What if you forget to take Hepcinat-LP Tablet :
Should you forget a Hepcinat-LP Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hepcinat-LP Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently